Luke Maggs

484 total citations
16 papers, 332 citations indexed

About

Luke Maggs is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Luke Maggs has authored 16 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Immunology and 4 papers in Biomedical Engineering. Recurrent topics in Luke Maggs's work include CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Luke Maggs is often cited by papers focused on CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Luke Maggs collaborates with scholars based in United States, United Kingdom and Vietnam. Luke Maggs's co-authors include Soldano Ferrone, Ali Sanjari Moghaddam, Giulia Cattaneo, Ananthan Sadagopan, Cristina R. Ferrone, Francesca Kinsella, Xinhui Wang, Jane Nunnick, Charles Craddock and Paul Moss and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Cancer Research and European Journal of Immunology.

In The Last Decade

Luke Maggs

15 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luke Maggs United States	11	201	163	67	57	54	16	332
Abishek Vaidya United States	9	215 1.1×	128 0.8×	103 1.5×	44 0.8×	27 0.5×	19	330
Michael Chrobok Sweden	9	245 1.2×	245 1.5×	120 1.8×	34 0.6×	69 1.3×	11	436
Antonia Rotolo United States	8	229 1.1×	178 1.1×	93 1.4×	31 0.5×	108 2.0×	29	395
Marion Alcantara France	9	259 1.3×	121 0.7×	103 1.5×	49 0.9×	16 0.3×	24	402
Gangli An China	12	340 1.7×	257 1.6×	137 2.0×	57 1.0×	78 1.4×	24	490
Kathryn Ruisaard United States	9	324 1.6×	272 1.7×	160 2.4×	43 0.8×	77 1.4×	16	507
Antonio Valeri Spain	12	294 1.5×	303 1.9×	124 1.9×	28 0.5×	96 1.8×	23	462
Anna Capsomidis United Kingdom	5	381 1.9×	397 2.4×	129 1.9×	62 1.1×	29 0.5×	7	622
Anne W. J. Martens Netherlands	10	196 1.0×	248 1.5×	73 1.1×	28 0.5×	20 0.4×	12	396
Tiina Hannunen Finland	4	139 0.7×	125 0.8×	100 1.5×	35 0.6×	50 0.9×	4	285

Countries citing papers authored by Luke Maggs

Since Specialization

Citations

This map shows the geographic impact of Luke Maggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Maggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Maggs more than expected).

Fields of papers citing papers by Luke Maggs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Maggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Maggs. The network helps show where Luke Maggs may publish in the future.

Co-authorship network of co-authors of Luke Maggs

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Maggs. A scholar is included among the top collaborators of Luke Maggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Maggs. Luke Maggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Maggs, Luke, et al.. (2025). Piperlongumine enhances the antitumor efficacy of PD-1 inhibitors by inducing immunogenic cell death in prostate cancer cells. World Journal of Urology. 43(1). 406–406. 1 indexed citations

Cattaneo, Giulia, Jingyu Jia, Luke Maggs, et al.. (2025). B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer. Journal of Experimental & Clinical Cancer Research. 44(1). 248–248. 1 indexed citations

Cattaneo, Giulia, Jingyu Jia, Maria Chiara Gelmi, et al.. (2024). Chimeric Antigen Receptor T Cell with an Inducible Caspase-9 Suicide Gene Eradicates Uveal Melanoma Liver Metastases via B7-H3 Targeting. Clinical Cancer Research. 30(15). 3243–3258. 14 indexed citations

Cattaneo, Giulia, Jingyu Jia, Luke Maggs, et al.. (2023). 317 B7-H3-targeted CAR T cell with an inducible caspase 9 suicide gene effectively eradicates uveal melanoma liver metastases. SHILAP Revista de lepidopterología. A360–A360. 1 indexed citations

Cattaneo, Giulia, Luke Maggs, Jingyu Jia, et al.. (2023). B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers. Frontiers in Oncology. 13. 1193963–1193963. 15 indexed citations

Cattaneo, Giulia, Jingyu Jia, Luke Maggs, et al.. (2023). 239 CSPG4-targeted CAR T cells demonstrate potent antitumor activity in an orthotopic murine model of anaplastic thyroid cancer. SHILAP Revista de lepidopterología. A275–A275.

Cattaneo, Giulia, et al.. (2023). Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy. JAMA Oncology. 10(1). 115–115. 17 indexed citations

Shaw, Katie, et al.. (2021). Raspberry Pi nest cameras: An affordable tool for remote behavioral and conservation monitoring of bird nests. Ecology and Evolution. 11(21). 14585–14597. 12 indexed citations

Maggs, Luke, Ananthan Sadagopan, Ali Sanjari Moghaddam, & Soldano Ferrone. (2021). HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy. Trends in cancer. 7(12). 1089–1101. 45 indexed citations

10.

Maggs, Luke, et al.. (2021). CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma. Frontiers in Neuroscience. 15. 662064–662064. 109 indexed citations

11.

Michelakos, Theodoros, Filippos Kontos, Omar Barakat, et al.. (2020). B7-H3 targeted antibody-based immunotherapy of malignant diseases. Expert Opinion on Biological Therapy. 21(5). 587–602. 28 indexed citations

12.

Kontos, Filippos, Luke Maggs, Giulia Cattaneo, et al.. (2020). Radiation Enhances the Efficacy of B7-H3 Chimeric Antigen Receptor (CAR) T-Cell Based Immunotherapy for Triple Negative Breast Cancer (TNBC). Journal of the American College of Surgeons. 231(4). S40–S41. 1 indexed citations

13.

Maggs, Luke & Soldano Ferrone. (2020). Improving the Clinical Significance of Preclinical Immunotherapy Studies through Incorporating Tumor Microenvironment–like Conditions. Clinical Cancer Research. 26(17). 4448–4453. 13 indexed citations

14.

Kinsella, Francesca, Jianmin Zuo, Charlotte Inman, et al.. (2019). Mixed chimerism established by hematopoietic stem cell transplantation is maintained by host and donor T regulatory cells. Blood Advances. 3(5). 734–743. 24 indexed citations

15.

Chan, Y L Tracey, Jianmin Zuo, Charlotte Inman, et al.. (2017). NK cells produce high levels of IL‐10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. European Journal of Immunology. 48(2). 316–329. 31 indexed citations

16.

Maggs, Luke, Francesca Kinsella, Y L Tracey Chan, et al.. (2017). The number of CD56dim NK cells in the graft has a major impact on risk of disease relapse following allo-HSCT. Blood Advances. 1(19). 1589–1597. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact